Utility of the Phoenix-8 and PELOD-2 scales in pediatric patients with sepsis and acute lymphoblastic leukemia admitted to a pediatric intensive care unit at a quaternary-level hospital in Bogotá, Colombia, 2022–2024

Simple item page
dc.contributor.authorLudwing Jose Gallo-Motta
dc.contributor.authorAngela María Lince-González
dc.contributor.authorDiana Lucia Bravo-Guerra
dc.contributor.authorCarlos Alberto Pardo Gonzalez
dc.contributor.authorRodrigo Pérez-Morales
dc.contributor.authorJuan D. Roa G
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:03:36Z
dc.date.available2026-03-22T20:03:36Z
dc.date.issued2026
dc.description.abstractPhoenix-8 and PELOD-2 demonstrated moderate discriminative ability at admission but excellent performance at 72 h, making them clinically useful and comparable tools for prognostic stratification in children with ALL and sepsis.
dc.identifier.doi10.3389/fped.2026.1766687
dc.identifier.urihttps://doi.org/10.3389/fped.2026.1766687
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/79744
dc.language.isoen
dc.publisherFrontiers Media
dc.relation.ispartofFrontiers in Pediatrics
dc.sourceFundación para el Desarrollo de la Ecología
dc.subjectMedicine
dc.subjectPediatric intensive care unit
dc.subjectSepsis
dc.subjectMechanical ventilation
dc.subjectReceiver operating characteristic
dc.subjectLymphoblastic Leukemia
dc.subjectCohort
dc.subjectRetrospective cohort study
dc.subjectIntensive care unit
dc.subjectIntensive care
dc.titleUtility of the Phoenix-8 and PELOD-2 scales in pediatric patients with sepsis and acute lymphoblastic leukemia admitted to a pediatric intensive care unit at a quaternary-level hospital in Bogotá, Colombia, 2022–2024
dc.typearticle

Files

Collections

Artículo Científico Publicado